These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20676970)

  • 1. Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia.
    Sumitomo N; Nakamura T; Fukuhara J; Nakai T; Watanabe I; Mugishima H; Hiraoka M
    Heart Vessels; 2010 Sep; 25(5):448-52. PubMed ID: 20676970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vein isolation in patients with Brugada syndrome and atrial fibrillation: a 2-year follow-up.
    Conte G; Chierchia GB; Wauters K; De Asmundis C; Sarkozy A; Levinstein M; Sieira J; Baltogiannis G; Di Giovanni G; Ciconte G; Casado-Arroyo R; Saitoh Y; Brugada P
    Europace; 2014 Apr; 16(4):528-32. PubMed ID: 24108229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with Brugada syndrome and an implantable cardioverter-defibrillator to prevent inappropriate shock therapy.
    Kitamura T; Fukamizu S; Kawamura I; Hojo R; Aoyama Y; Komiyama K; Nishizaki M; Hiraoka M; Sakurada H
    Heart Rhythm; 2016 Jul; 13(7):1455-9. PubMed ID: 26961302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vein orifice isolation for eliminating paroxysmal atrial fibrillation after ICD implantation.
    Sueda T; Orihashi K; Watari M; Okada K; Ishii O
    Ann Thorac Cardiovasc Surg; 2001 Apr; 7(2):119-21. PubMed ID: 11371285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of pulmonary vein isolation in patients with paroxysmal atrial fibrillation and Brugada syndrome.
    Mugnai G; Hünük B; Ströker E; Ruggiero D; Coutino-Moreno HE; Takarada K; De Regibus V; Choudhury R; Abugattas de Torres JP; Moran D; Iacopino S; Filannino P; Conte G; Sieira J; Poelaert J; Beckers S; Brugada P; de Asmundis C; Chierchia GB
    Europace; 2018 Mar; 20(3):548-554. PubMed ID: 28340057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
    Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
    Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency catheter ablation for drug-refractory atrial tachyarrhythmias in a patient with catecholaminergic polymorphic ventricular tachycardia: A case report.
    Kawada S; Morita H; Watanabe A; Ito H
    J Cardiol Cases; 2019 Jan; 19(1):36-39. PubMed ID: 30693058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of pulmonary vein isolation and catheter renal denervation in atrial fibrillation complicated with uncontrolled hypertension: Mapping the renal sympathetic nerve and pulmonary vein (the pulmonary vein isolation plus renal denervation strategy)?
    Chen S; Kiuchi MG; Yin Y; Liu S; Schratter A; Acou WJ; Meyer C; Pürerfellner H; Chun KRJ; Schmidt B
    J Cardiovasc Electrophysiol; 2019 May; 30(5):658-667. PubMed ID: 30680830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagal modification can be a valid predictor of late recurrence of paroxysmal atrial fibrillation independent of the pulmonary vein isolation technique.
    Yamada T; Yoshida N; Murakami Y; Okada T; Yoshida Y; Muto M; Inden Y; Murohara T
    Circ J; 2009 Sep; 73(9):1606-11. PubMed ID: 19609042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case with catecholaminergic polymorphic ventricular tachycardia unmasked after successful ablation of atrial tachycardias from pulmonary veins.
    Sugiyasu A; Oginosawa Y; Nogami A; Hata Y
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):e21-4. PubMed ID: 19712071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design : The ASAF trial: ablation of sympathetic atrial fibrillation.
    de Jong MR; Hoogerwaard AF; Adiyaman A; Smit JJJ; Ramdat Misier AR; Heeg JE; van Hasselt BAAM; Van Gelder IC; Crijns HJGM; Lozano IF; Toquero Ramos JE; Javier Alzueta F; Ibañez B; Rubio JM; Arribas F; Porres Aracama JM; Brugada J; Mont L; Elvan A
    Clin Res Cardiol; 2018 Jul; 107(7):539-547. PubMed ID: 29487995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of implantable cardioverter-defibrillator programming and shock interpretation in treatment-refractory catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Hart A; Krahn AD; Sanatani S
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):569-571. PubMed ID: 31090560
    [No Abstract]   [Full Text] [Related]  

  • 16. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visually guided pulmonary vein isolation in patients with persistent atrial fibrillation.
    Bordignon S; Boehmer MC; Klostermann A; Fuernkranz A; Perrotta L; Dugo D; Chun KR; Schmidt B
    Europace; 2016 Apr; 18(4):538-42. PubMed ID: 26316147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks.
    Miyazaki S; Taniguchi H; Kusa S; Komatsu Y; Ichihara N; Takagi T; Iwasawa J; Kuroi A; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Europace; 2015 Feb; 17(2):289-94. PubMed ID: 25061229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter Ablation of Paroxysmal Atrial Fibrillation: Have We Achieved Cure with Pulmonary Vein Isolation?
    Santangeli P; Lin D
    Methodist Debakey Cardiovasc J; 2015; 11(2):71-5. PubMed ID: 26306122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.